Analyze Diet

Prevalence of Clostridioides difficile in hospitalized neonatal mare-foal pairs from Alberta and direct comparison of fecal culture with toxin gene detection.

Abstract: is an important pathogen in the feces of adult horses and foals. It can be clinically diagnosed using several testing methods, including culture isolation and, more commonly, direct toxin gene detection from feces using molecular methods. The importance of monitoring shedding in foals or dams during hospitalization remains unclear. The objectives of this study were to determine the prevalence of fecal shedding in mare-foal pairs and to compare detection using isolation and a commercial real-time polymerase chain reaction (qPCR) for toxin A and B genes in feces. Foals and their mares admitted to a veterinary hospital were enrolled in the study and their fecal samples were tested for toxin A and B genes using qPCR and by culture using selective media. A total of 66 mare-foal pairs was included. Overall, fecal qPCR for toxin A and B genes was positive in 29/132 samples from mares and foals and all positive samples originated from foal fecal samples (29/66). A total of 95 samples were negative on both testing modalities (61 mares and 34 foals) and 24 samples were positive on both tests (24 foals). Eight samples (5 mares and 3 foals) were culture positive and qPCR negative, although all of the culture isolates were positive for A and B genes on subsequent conventional PCR testing. Five samples were positive for toxin genes using qPCR and negative using culture. The most common ribotype detected was 078. Two mare-foal pairs cultured positive, of which one pair shared the same ribotype. est un agent pathogène important présent dans les fèces des chevaux adultes et des poulains. Son diagnostic clinique repose sur plusieurs méthodes, notamment l’isolement par culture et, plus fréquemment, la détection directe des gènes de toxines dans les fèces par des méthodes moléculaires. L’importance du suivi de l’excrétion de chez les poulains et leurs mères hospitalisés reste incertain. Cette étude visait à déterminer la prévalence de l’excrétion fécale de chez les couples jument-poulain et à comparer la détection par isolement et détection des gènes des toxines A et B dans les fèces par PCR quantitative en temps réel (qPCR) commerciale. Les poulains et leurs juments admis dans un hôpital vétérinaire ont été inclus dans l’étude et leurs échantillons fécaux ont été analysés pour la recherche des gènes des toxines A et B de par qPCR et par culture sur milieux sélectifs. Au total, 66 paires jument-poulain ont été inclus. Globalement, la qPCR fécale pour les gènes des toxines A et B de s’est révélée positive dans 29/132 échantillons provenant de juments et de poulains, tous les échantillons positifs étant issus de fèces de poulains (29/66). Au total, 95 échantillons étaient négatifs aux deux tests (61 juments et 34 poulains) et 24 échantillons étaient positifs aux deux tests (24 poulains). Huit échantillons (5 juments et 3 poulains) étaient positifs en culture et négatifs en qPCR, bien que tous les isolats de culture aient été positifs pour les gènes A et B lors de tests PCR conventionnels ultérieurs. Cinq échantillons étaient positifs pour les gènes des toxines en qPCR et négatifs en culture. Le ribotype le plus fréquemment détecté était le 078. Deux paires jument-poulain ont présenté une culture positive, dont une paire partageant le même ribotype.(Traduit par Docteur Serge Messier).
Publication Date: 2026-07-01 PubMed ID: 42460136PubMed Central: PMC13370171
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated how common Clostridioides difficile (C. difficile) shedding is in hospitalized mare-foal pairs and compared two methods—fecal culture and real-time PCR (qPCR)—for detecting the bacterium’s toxin genes in feces.

Background

  • Clostridioides difficile is a bacterium known to cause disease in adult horses and foals, particularly in hospital settings.
  • It produces toxins A and B, which are the primary virulence factors responsible for symptoms.
  • Diagnostic methods typically involve:
    • Culture isolation of the bacterium from feces.
    • Molecular detection of toxin genes (A and B) directly from fecal samples using qPCR.
  • The clinical importance of monitoring fecal shedding of C. difficile in hospitalized foals and their mares is not well established.

Study Objectives

  • Determine the prevalence of fecal shedding of C. difficile in hospitalized mare-foal pairs.
  • Compare the detection results of two methods: the culture isolation method and a commercial real-time PCR assay for toxin A and B genes.

Methods

  • Subjects: 66 mare-foal pairs admitted to a veterinary hospital in Alberta.
  • Sample Collection: Fecal samples collected from both mares and foals.
  • Testing Procedures:
    • Culturing of feces on selective media to isolate C. difficile bacteria.
    • Commercial real-time PCR (qPCR) to detect toxin A and B genes directly in feces.
    • Subsequent conventional PCR testing on culture isolates to confirm toxin genes.

Key Findings

  • Prevalence by qPCR: 29 positive samples for toxin genes out of 132 total (66 mares + 66 foals), and all positives were from foals (29/66 foals positive).
  • Culture and qPCR concordance:
    • 95 samples were negative by both culture and qPCR (61 mares and 34 foals).
    • 24 samples were positive by both methods (all 24 from foals).
  • Discrepant results:
    • Eight samples (5 mares and 3 foals) were culture-positive but qPCR-negative; however, toxin genes were confirmed in these isolates via conventional PCR after culture.
    • Five samples were qPCR-positive but culture-negative, indicating that sometimes molecular detection is more sensitive or culture conditions may not always recover bacteria.
  • Ribotyping results:
    • The most common ribotype detected was 078, a ribotype known to cause disease in animals and humans.
    • Two mare-foal pairs had culture-positive isolates, and in one pair, both shared the same ribotype, suggesting possible transmission or common source.

Interpretation and Importance

  • The study highlights that C. difficile shedding was observed exclusively in foals and not in mares via qPCR, although some mares were culture-positive.
  • Both detection methods have value but may differ in sensitivity; thus, combining culture and molecular testing gives a more complete picture.
  • The presence of common ribotypes between mare and foal pairs suggests potential transmission during hospitalization or a shared environment.
  • The findings emphasize the need for monitoring C. difficile shedding in hospitalized foals, as this could impact infection control and clinical outcomes.

Limitations and Considerations

  • The study is limited to hospitalized mare-foal pairs from a single region (Alberta), so prevalence may vary elsewhere.
  • Discrepancies between culture and molecular detection indicate that each test may have limitations, such as culture sensitivity and PCR inhibitors.
  • Further research is necessary to assess the clinical implications of shedding and potential transmission dynamics in hospital settings.

Cite This Article

APA
Whitehead AE, Borges AS, Zakia LS, Yu S, Surette MG, Arroyo LG. (2026). Prevalence of Clostridioides difficile in hospitalized neonatal mare-foal pairs from Alberta and direct comparison of fecal culture with toxin gene detection. Can J Vet Res, 90(3), 111-117.

Publication

ISSN: 1928-9022
NlmUniqueID: 8607793
Country: Canada
Language: English
Volume: 90
Issue: 3
Pages: 111-117

Researcher Affiliations

Whitehead, Ashley E
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta T3R 1J3 (Whitehead); Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1 (Borges, Zakia, Yu, Arroyo); Department of Medicine, Farncombe Family Digestive Health Research Institute, Health Sciences Centre, McMaster University, Hamilton, Ontario L8S 4K1 (Surette).
Borges, Alexandre S
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta T3R 1J3 (Whitehead); Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1 (Borges, Zakia, Yu, Arroyo); Department of Medicine, Farncombe Family Digestive Health Research Institute, Health Sciences Centre, McMaster University, Hamilton, Ontario L8S 4K1 (Surette).
Zakia, Luiza S
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta T3R 1J3 (Whitehead); Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1 (Borges, Zakia, Yu, Arroyo); Department of Medicine, Farncombe Family Digestive Health Research Institute, Health Sciences Centre, McMaster University, Hamilton, Ontario L8S 4K1 (Surette).
Yu, Serena
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta T3R 1J3 (Whitehead); Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1 (Borges, Zakia, Yu, Arroyo); Department of Medicine, Farncombe Family Digestive Health Research Institute, Health Sciences Centre, McMaster University, Hamilton, Ontario L8S 4K1 (Surette).
Surette, Michael G
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta T3R 1J3 (Whitehead); Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1 (Borges, Zakia, Yu, Arroyo); Department of Medicine, Farncombe Family Digestive Health Research Institute, Health Sciences Centre, McMaster University, Hamilton, Ontario L8S 4K1 (Surette).
Arroyo, Luis G
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta T3R 1J3 (Whitehead); Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1 (Borges, Zakia, Yu, Arroyo); Department of Medicine, Farncombe Family Digestive Health Research Institute, Health Sciences Centre, McMaster University, Hamilton, Ontario L8S 4K1 (Surette).

MeSH Terms

  • Animals
  • Horses
  • Female
  • Feces / microbiology
  • Horse Diseases / epidemiology
  • Horse Diseases / microbiology
  • Clostridioides difficile / isolation & purification
  • Clostridioides difficile / genetics
  • Clostridium Infections / veterinary
  • Clostridium Infections / epidemiology
  • Clostridium Infections / microbiology
  • Bacterial Toxins / genetics
  • Bacterial Toxins / metabolism
  • Prevalence
  • Animals, Newborn
  • Alberta / epidemiology
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Enterotoxins / genetics

References

This article includes 42 references
  1. Weese JS. Clostridium (Clostridioides) difficile in animals.. J Vet Diagn Invest 2020;32:213–221.
    pmc: PMC7081495pubmed: 31904312
  2. Schoster A, Staempfli H. Epidemiology and antimicrobial resistance in Clostridium difficile with special reference to the horse.. Curr Clin Microbiol Rep 2016;3:32–41.
  3. Polage CR, Gyorke CE, Kennedy MA. Overdiagnosis of Clostridium difficile infection in the molecular test era.. JAMA Intern Med 2015;175:1792–1801.
    pmc: PMC4948649pubmed: 26348734
  4. Jones RL, Adney WS, Shideler RK. Isolation of Clostridium difficile and detection of cytotoxin in the feces of diarrheic foals in the absence of antimicrobial treatment.. J Clin Microbiol 1987;25:1225–1227.
    pmc: PMC269181pubmed: 3112178
  5. Madewell BR, Tang YJ, Jang S. Apparent outbreaks of Clostridium difficile-associated diarrhea in horses in a veterinary medical teaching hospital.. J Vet Diagn Invest 1995;7:343–346.
    pubmed: 7578449
  6. Magdesian KG, Leutenegger CM. Real-time PCR and typing of Clostridium difficile isolates colonizing mare-foal pairs.. Vet J 2011;190:119–123.
    pubmed: 21035363
  7. Silva RO, Ribeiro MG, Palhares MS. Detection of A/B toxin and isolation of Clostridium difficile and Clostridium perfringens from foals.. Equine Vet J 2013;45:671–675.
    pubmed: 23452044
  8. Weese JS, Slovis N, Rousseau J. Clostridioides (Clostridium) difficile in neonatal foals and mares at a referral hospital.. J Vet Intern Med 2021;35:1140–1146.
    pmc: PMC7995440pubmed: 33656757
  9. Persson S, Torpdahl M, Olsen KE. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.. Clin Microbiol Infect 2008;14:1057–1064.
    pubmed: 19040478
  10. Fawley WN, Knetsch CW, MacCannell DR. Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile.. PLoS One 2015;10:e0118150.
    pmc: PMC4332677pubmed: 25679978
  11. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa.. J Clin Epidemiol 1993;46:423–429.
    pubmed: 8501467
  12. Landis JR, Koch GG. The measurement of observer agreement for categorical data.. Biometrics 1977;33:159–174.
    pubmed: 843571
  13. McHugh ML. Interrater reliability: The kappa statistic.. Biochem Med (Zagreb) 2012;22:276–282.
    pmc: PMC3900052pubmed: 23092060
  14. Thean S, Elliott B, Riley TV. Clostridium difficile in horses in Australia — A preliminary study.. J Med Microbiol 2011;60:1188–1192.
    pubmed: 21436371
  15. Weese JS, Staempfli HR, Prescott JF. A prospective study of the roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhoea.. Equine Vet J 2001;33:403–409.
    pubmed: 11469775
  16. Medina-Torres CE, Weese JS, Staempfli HR. Prevalence of Clostridium difficile in horses. Vet Microbiol. 2011;152:212–215.
    pubmed: 21570780
  17. Båverud V, Gustafsson A, Franklin A, Aspán A, Gunnarsson A. Clostridium difficile: Prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet J. 2003;35:465–471.
    pubmed: 12875324
  18. Schoster A, Kunz T, Lauper M, Graubner C, Schmitt S, Weese JS. Prevalence of Clostridium difficile and Clostridium perfringens in Swiss horses with and without gastrointestinal disease and microbiota composition in relation to Clostridium difficile shedding. Vet Microbiol. 2019;239:108433.
    pubmed: 31767096
  19. Morsi A, Elsohaby I, Abdelmageed M, Al-Marri T, Fayez M. Clostridium difficile infections in adult horses and foals: Prevalence and associated risk factors. Adv Anim Vet Sci. 2019;7:169–174.
  20. Kecerova Z, Cizek A, Nyc O, Krutova M. Clostridium difficile isolates derived from Czech horses are resistant to enrofloxacin; cluster to clades 1 and 5 and ribotype 033 predominates. Anaerobe. 2019;56:17–21.
    pubmed: 30630037
  21. Lee YR, Lee K, Byun JW, et al. Prevalence, genetic characteristics, and antimicrobial resistance of Clostridioides difficile isolates from horses in Korea. Anaerobe. 2023;80:102700.
    pubmed: 36716814
  22. Ossiprandi MC, Buttrini M, Bottarelli E, Zerbini L. Preliminary molecular analysis of Clostridium difficile isolates from healthy horses in northern Italy. Comp Immunol Microbiol Infect Dis. 2010;33:e25–29.
    pubmed: 20004974
  23. Olivo G, Lucas TM, Borges AS, et al. Enteric pathogens and coinfections in foals with and without diarrhea. Biomed Res Int. 2016:1512690.
    pmc: PMC5223019pubmed: 28116290
  24. Schoster A, Staempfli HR, Abrahams M, Jalali M, Weese JS, Guardabassi L. Effect of a probiotic on prevention of diarrhea and Clostridium difficile and Clostridium perfringens shedding in foals. J Vet Intern Med. 2015;29:925–931.
    pmc: PMC4895414pubmed: 25903509
  25. Donaldson MT, Palmer JE. Prevalence of Clostridium perfringens enterotoxin and Clostridium difficile toxin A in feces of horses with diarrhea and colic. J Am Vet Med Assoc. 1999;215:358–361.
    pubmed: 10434974
  26. Diab SS, Rodriguez-Bertos A, Uzal FA. Pathology and diagnostic criteria of Clostridium difficile enteric infection in horses. Vet Pathol. 2013;50:1028–1036.
    pubmed: 23686768
  27. Magdesian KG, Barnum S, Pusterla N. Fecal PCR testing for detection of Clostridium perfringens and Clostridioides difficile toxin genes and other pathogens in foals with diarrhea: 28 cases. J Vet Diagn Invest. 2022;34:396–401.
    pmc: PMC9254072pubmed: 34554023
  28. Frederick J, Giguère S, Sanchez LC. Infectious agents detected in the feces of diarrheic foals: A retrospective study of 233 cases (2003–2008) J Vet Intern Med. 2009;23:1254–1260.
    pmc: PMC7166729pubmed: 19747192
  29. Slovis NM, Elam J, Estrada M, Leutenegger CM. Infectious agents associated with diarrhoea in neonatal foals in central Kentucky: A comprehensive molecular study. Equine Vet J. 2014;46:311–316.
    pmc: PMC7163618pubmed: 23773143
  30. Båverud V, Franklin A, Gunnarsson A, Gustafsson A, Hellander-Edman A. Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia. Equine Vet J. 1998;30:482–488.
    pubmed: 9844966
  31. Uchida-Fujii E, Niwa H, Senoh M, et al. Clostridioides difficile infection in thoroughbred horses in Japan from 2010 to 2021. Sci Rep. 2023;13:13099.
    pmc: PMC10421859pubmed: 37567893
  32. Silva RO, Rupnik M, Diniz AN, Vilela EG, Lobato FC. Clostridium difficile ribotypes in humans and animals in Brazil. Mem Inst Oswaldo Cruz. 2015;110:1062–1065.
    pmc: PMC4708028pubmed: 26676318
  33. Schoster A, Staempfli HR, Arroyo LG, et al. Longitudinal study of Clostridium difficile and antimicrobial susceptibility of Escherichia coli in healthy horses in a community setting. Vet Microbiol. 2012;159:364–370.
    pubmed: 22554764
  34. Schoster A, Arroyo LG, Staempfli HR, Shewen PE, Weese JS. Presence and molecular characterization of Clostridium difficile and Clostridium perfringens in intestinal compartments of healthy horses. BMC Vet Res. 2012;8:94.
    pmc: PMC3514389pubmed: 22748233
  35. Hain-Saunders NMR, Knight DR, Bruce M, Byrne D, Riley TV. Genomic analysis of Clostridioides difficile recovered from horses in Western Australia. Microorganisms. 2023;11:1743.
    pmc: PMC10386058pubmed: 37512915
  36. Rodriguez C, Taminiau B, Brevers B, et al. Carriage and acquisition rates of Clostridium difficile in hospitalized horses, including molecular characterization, multilocus sequence typing and antimicrobial susceptibility of bacterial isolates. Vet Microbiol. 2014;172:309–317.
    pubmed: 24894133
  37. Barbut F, Mastrantonio P, Delmée M, Brazier J, Kuijper E, Poxton I. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect. 2007;13:1048–1057.
    pubmed: 17850341
  38. Bauer MP, Notermans DW, van Benthem BHB, et al. Clostridium difficile infection in Europe: A hospital-based survey. Lancet. 2011;377:63–73.
    pubmed: 21084111
  39. Martin H, Willey B, Low DE, et al. Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. J Clin Microbiol. 2008;46:2999–3004.
    pmc: PMC2546775pubmed: 18650360
  40. Gerding DN, Johnson S, Rupnik M, Aktories K. Clostridium difficile binary toxin CDT. Gut Microbes. 2014;5:15–27.
    pmc: PMC4049931pubmed: 24253566
  41. Nho SW, Kim M, Kim SJ, et al. Pragmatic strategy for fecal specimen storage and the corresponding test methods for Clostridioides difficile diagnosis. Pathogens. 2021;10:1049.
    pmc: PMC8400358pubmed: 34451512
  42. Peterson LR, Young SA, Davis TE, Jr, et al. Evaluation of the cobas Cdiff test for detection of toxigenic Clostridium difficile in stool samples. J Clin Microbiol. 2017;55:3426–3436.
    pmc: PMC5703809pubmed: 28954901

Citations

This article has been cited 0 times.